Hindson Benjamin J. 的 Form 4 申報
10x Genomics, Inc.（TXG），2021/10/5 申報
- 申報編號
- 0001567619-21-017948
- 申報時間
- 2021/10/5
- 交易日
- 2021/10/1
- 申報延遲
- 4 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 5 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $598.2 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Hindson Benjamin J.CIK 0001786391 | 董事、高階主管（見申報備註） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/10/1 | Class A Common Stock | M行使選擇權取得 | +41,666 | $5.04 | +$209,996.64 | 88,783 | 直接 | |
| 2021/10/1 | Class A Common Stock | S賣出處分 | −4,400 | $142.16F2 | −$625,504 | 84,383 | 直接 | |
| 2021/10/1 | Class A Common Stock | S賣出處分 | −13,297 | $143.13F3 | −$1,903,199.61 | 71,086 | 直接 | |
| 2021/10/1 | Class A Common Stock | S賣出處分 | −21,469 | $143.97F4 | −$3,090,891.93 | 49,617 | 直接 | |
| 2021/10/1 | Class A Common Stock | S賣出處分 | −2,500 | $144.77F5 | −$361,925 | 47,117 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/10/1 | Class A Common Stock | M行使選擇權處分 | −41,666 | $0.00 | $0 | 61,116 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This transaction was executed in multiple trades at prices ranging from $141.53 to $142.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
This transaction was executed in multiple trades at prices ranging from $142.53 to $143.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $143.53 to $144.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
This transaction was executed in multiple trades at prices ranging from $144.54 to $145.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
備註
Chief Scientific Officer and President